MEK Inhibitors for the Treatment of Low-Grade Serous Ovarian Cancer: Expanding Therapeutic Options for a Rare Ovarian Cancer Subtype

David M. Gershenson, Charlie Gourley, James Paul

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)JCO.20.02190
JournalJournal of Clinical Oncology
DOIs
Publication statusPublished - 8 Sep 2020

Cite this